NeuroFlow, a behavioral health company, secured a $25 million investment led by growth equity impact investor SEMCAP Health, bringing its total funding to $32 million.
The company raised $7.5 million in a Series A funding round in 2019 and $20 million in Series B financing in 2021.
WHAT THEY DO
NeuroFlow’s cloud-based platform allows healthcare providers to track, assess and connect with patients between traditional office visits. The company also offers AI-driven clinical decision support with recommendations for the next steps for individual patients.
The Pennsylvania-based company will use the funds to expand its network and increase R&D investments to grow its platform. It will also increase its workforce in all departments.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
“We’re excited to bring in a strong partner like SEMCAP to support our next stage of growth. This gives us the opportunity to meet the demand we are experiencing and to invest in a platform that helps deliver a happier, healthier quality of life for those across the spectrum of mental health needs. With this financing, we’ll focus on strategic hiring, R&D for the platform and the launch of a Spanish-language app,” James Kanka, NeuroFlow’s vice president of marketing, told MobiHealthNews in an email.
MARKET SNAPSHOT
Last month, NeuroFlow announced a collaboration with CirrusMD, a startup offering on-demand, text-based telehealth, where CirrusMD would leverage NeuroFlow’s clinical decision support platform, patient engagement tools and intervention services.
In February, NeuroFlow announced a partnership with Aflac, giving the insurance provider’s employees access to digital mental health resources via NeuroFlow’s educational content service.
Source: Mobihealthnews